Comments
Loading...

Surmodics Analyst Ratings

SRDXNASDAQ
Logo brought to you by Benzinga Data
$30.75
0.140.46%
At close: -
$30.75
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$43.00
Lowest Price Target1
$43.00
Consensus Price Target1
$43.00

Surmodics Analyst Ratings and Price Targets | NASDAQ:SRDX | Benzinga

Surmodics Inc has a consensus price target of $43 based on the ratings of 4 analysts. The high is $43 issued by Lake Street on March 7, 2025. The low is $43 issued by Lake Street on March 7, 2025. The 3 most-recent analyst ratings were released by Lake Street, Lake Street, and Sidoti & Co. on March 7, 2025, May 29, 2024, and May 29, 2024, respectively. With an average price target of $43 between Lake Street, Lake Street, and Sidoti & Co., there's an implied 39.84% upside for Surmodics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Nov 24
0
0
0
0
Jan
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Lake Street
Sidoti & Co.

1calculated from analyst ratings

Analyst Ratings for Surmodics

Buy NowGet Alert
03/07/2025Buy Now39.84%Lake Street
Brooks O'Neil36%
$43 → $43UpgradeHold → BuyGet Alert
01/30/2025Buy NowNeedham
Mike Matson57%
ReiteratesHold → HoldGet Alert
11/07/2024Buy NowNeedham
Mike Matson57%
Reiterates → HoldGet Alert
08/05/2024Buy NowNeedham
Mike Matson57%
Reiterates → HoldGet Alert
05/30/2024Buy NowBarrington Research
Michael Petusky52%
DowngradeOutperform → Market PerformGet Alert
05/29/2024Buy Now39.84%Lake Street
Brooks O'Neil36%
→ $43DowngradeBuy → HoldGet Alert
05/29/2024Buy Now39.84%Sidoti & Co.
James Sidoti65%
→ $43DowngradeBuy → NeutralGet Alert
05/29/2024Buy NowNeedham
Mike Matson57%
DowngradeBuy → HoldGet Alert
05/02/2024Buy Now130.89%Barrington Research
Michael Petusky52%
$71 → $71MaintainsOutperformGet Alert
05/01/2024Buy Now39.84%Needham
Mike Matson57%
$47 → $43MaintainsBuyGet Alert
04/10/2024Buy Now52.85%Needham
Mike Matson57%
$47 → $47ReiteratesBuy → BuyGet Alert
02/01/2024Buy Now52.85%Needham
Mike Matson57%
$44 → $47MaintainsBuyGet Alert
11/09/2023Buy Now130.89%Barrington Research
Michael Petusky52%
$69 → $71MaintainsOutperformGet Alert
11/08/2023Buy Now43.09%Needham
Mike Matson57%
$50 → $44MaintainsBuyGet Alert
08/02/2023Buy Now62.6%Needham
Mike Matson57%
$36 → $50ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now124.39%Barrington Research
Michael Petusky52%
$60 → $69MaintainsOutperformGet Alert
06/20/2023Buy Now17.07%Needham
Mike Matson57%
→ $36ReiteratesBuy → BuyGet Alert
06/13/2023Buy Now17.07%Needham
Mike Matson57%
→ $36UpgradeHold → BuyGet Alert
02/13/2023Buy NowNeedham
Mike Matson57%
DowngradeBuy → HoldGet Alert
02/07/2023Buy Now95.12%Barrington Research
Michael Petusky52%
$61 → $60MaintainsOutperformGet Alert
02/07/2023Buy Now10.57%Needham
Mike Matson57%
$46 → $34MaintainsBuyGet Alert
01/20/2023Buy Now98.37%Barrington Research
Michael Petusky52%
$70 → $61MaintainsOutperformGet Alert
04/28/2022Buy Now49.59%Needham
Mike Matson57%
$58 → $46MaintainsBuyGet Alert

FAQ

Q

What is the target price for Surmodics (SRDX) stock?

A

The latest price target for Surmodics (NASDAQ:SRDX) was reported by Lake Street on March 7, 2025. The analyst firm set a price target for $43.00 expecting SRDX to rise to within 12 months (a possible 39.84% upside). 11 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Surmodics (SRDX)?

A

The latest analyst rating for Surmodics (NASDAQ:SRDX) was provided by Lake Street, and Surmodics upgraded their buy rating.

Q

When was the last upgrade for Surmodics (SRDX)?

A

The last upgrade for Surmodics Inc happened on March 7, 2025 when Lake Street raised their price target to $43. Lake Street previously had a hold for Surmodics Inc.

Q

When was the last downgrade for Surmodics (SRDX)?

A

The last downgrade for Surmodics Inc happened on May 30, 2024 when Barrington Research changed their price target from N/A to N/A for Surmodics Inc.

Q

When is the next analyst rating going to be posted or updated for Surmodics (SRDX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surmodics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surmodics was filed on March 7, 2025 so you should expect the next rating to be made available sometime around March 7, 2026.

Q

Is the Analyst Rating Surmodics (SRDX) correct?

A

While ratings are subjective and will change, the latest Surmodics (SRDX) rating was a upgraded with a price target of $43.00 to $43.00. The current price Surmodics (SRDX) is trading at is $30.75, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch